Therefore, an increased localization of C99 in MAM in AD may explain the upregulation of ER–mitochondria connections and MAM functionality seen in the disease (Area‐Gomez et al, 2012; Hedskog et al, 2013). This evidence concerns the gene APP and Alzheimer disease.